Answers are grounded in this paper and cite their sources.
Protein S (PS) is a 75kDa vitamin K-dependent glycoprotein secreted by hepatocytes, megakaryocytes, and endothelial cells. PS is an anticoagulant; functioning as a cofactor to activated protein C (APC) and tissue factor pathway inhibitor (TFPI) as well as acting to directly bind to and inhibit factor IXa (FIXa). PS has other functions including apoptosis, atherosclerosis and as a signaling molecule in the inflammatory pathway through the TAM (Tyro 3, Axl, Mer) family of tyrosine kinase receptors. The importance of PS is manifested by the lethality that could arise when a person has PS deficiency. There are three different types of PS deficiency-each varying in phenotypic lethality-that can lead to thrombotic episodes in a patient. Medication prescribed to treat those who are pro-thrombotic has shown to have its limitations; making the prospect of using PS as an infusion therapy very important. Conversely, with PS playing a roll to combat coagulation, using PS antibody as an adjunct hemophilic therapy could be a promising treatment for the future. Understanding PS and its various roles is of great importance to treat patients suffering from pro-thrombotic and hemophilic conditions.
No takes yet. Share an insight, caveat, or question.
Dorsey et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: